1![RTT / Muscular dystrophy / Medicine / Duchenne muscular dystrophy / Cost / Health / Neuromuscular disease / Medicare / Dystrophy / Clinical medicine / Prosensa RTT / Muscular dystrophy / Medicine / Duchenne muscular dystrophy / Cost / Health / Neuromuscular disease / Medicare / Dystrophy / Clinical medicine / Prosensa](/pdf-icon.png) | Add to Reading ListSource URL: www.actionduchenne.orgLanguage: English - Date: 2014-05-22 06:18:00
|
---|
2![Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. ( Privacy Policy and Notice of Information Practices Effective Date: April 27, 2015 BioMarin Pharmaceutical Inc. (](https://www.pdfsearch.io/img/a00eedf2282326fadd61aef4142d77b9.jpg) | Add to Reading ListSource URL: www.prosensa.euLanguage: English - Date: 2015-04-27 19:57:39
|
---|
3![Accelerating Access to Treatments of Duchenne CureDuchenne and Prosensa Debra Miller, Founder and CEO, CureDuchenne Celia Economides, Sr Director, IR and Corporate Communications, Prosensa Accelerating Access to Treatments of Duchenne CureDuchenne and Prosensa Debra Miller, Founder and CEO, CureDuchenne Celia Economides, Sr Director, IR and Corporate Communications, Prosensa](https://www.pdfsearch.io/img/9ec6f0f66f92bd8d463808fe373fa915.jpg) | Add to Reading ListSource URL: www.partneringforcures.orgLanguage: English - Date: 2014-12-01 15:31:54
|
---|
4![Prosensa announces commencement of redosing of drisapersen in North America in patients with Duchenne muscular dystrophy Leiden, The Netherlands, Sept. 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), th Prosensa announces commencement of redosing of drisapersen in North America in patients with Duchenne muscular dystrophy Leiden, The Netherlands, Sept. 17, 2014 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), th](https://www.pdfsearch.io/img/a35032e438f06bda7cf7605c4ad3b380.jpg) | Add to Reading ListSource URL: muscle.caLanguage: English - Date: 2014-09-22 14:00:28
|
---|